BIT 0.00% 2.5¢ biotron limited

merck looking for new hepatitis c programs

  1. 2,313 Posts.
    lightbulb Created with Sketch. 332
    Merck CEO Kenneth Frazier is deploying his deal team this year with some very specific instructions to step up their game. Speaking to an investor group, the CEO made it clear that the pharma giant needs more deals to add new therapies to the pipeline. And he's particularly interested in roping some new hepatitis C programs.

    http://www.fiercebiotech.com/story/merck-ceo-frazier-future-industry-going-be-more-partnerships/2012-01-05

    bluebush
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $22.55M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $23.83K 953.1K

Buyers (Bids)

No. Vol. Price($)
2 141000 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 36000 1
View Market Depth
Last trade - 15.15pm 22/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.